US 6,395,767 · Application 09/788,173 · Granted May 28, 2002
US 6,395,767
Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv and method
Estimated expiration
February 16, 2021
Expired 2049 days ago
Earliest effective filing
Feb 16, 2001
+ 20 years
Feb 16, 2021
PTA +0d
Feb 16, 2021
No TD
—
Final
Feb 16, 2021
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- February 16, 2001
- Earliest effective filing
- February 16, 2001
- Issue date
- May 28, 2002
- PTA
- 0 days
- Base expiry (before PTA)
- February 16, 2021
February 16, 2001 + 20 years = February 16, 2021
- PRO60/188,555 — Provisional — not used for base term
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 09/788,173 · US 6,395,767
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 6,395,767: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US6395767Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.